Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
EDQM
0
USP
0
JP
0
Others
0
Europe
0
Canada
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
Annual Reports
NA
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. Spinosyn-d
1. Spinosad Factor D
2. 131929-63-0
3. A 83543d
4. Chebi:9232
5. 78g4631rtt
6. (1s,2s,5r,7s,9s,10s,14r,15s,19s)-15-[(2r,5s,6r)-5-(dimethylamino)-6-methyloxan-2-yl]oxy-19-ethyl-4,14-dimethyl-7-[(2r,3r,4r,5s,6s)-3,4,5-trimethoxy-6-methyloxan-2-yl]oxy-20-oxatetracyclo[10.10.0.02,10.05,9]docosa-3,11-diene-13,21-dione
7. (2s,3ar,5as,5bs,9s,13s,14r,16as,16bs)-13-{[(2r,5s,6r)-5-(dimethylamino)-6-methyltetrahydro-2h-pyran-2-yl]oxy}-9-ethyl-4,14-dimethyl-7,15-dioxo-2,3,3a,5a,5b,6,7,9,10,11,12,13,14,15,16a,16b-hexadecahydro-1h-as-indaceno[3,2-d]oxacyclododecin-2-yl 6-deoxy-2,3,4-tri-o-methyl-alpha-l-mannopyranoside
8. 1h-as-indaceno3,2-doxacyclododecin-7,15-dione, 2-(6-deoxy-2,3,4-tri-o-methyl-.alpha.-l-mannopyranosyl)oxy-13-(2r,5s,6r)-5-(dimethylamino)tetrahydro-6-methyl-2h-pyran-2-yloxy-9-ethyl-2,3,3a,5a,5b,6,9,10,11,12,13,14,16a,16b-tetradecahydro-4,14-dimethyl-, (2
9. Spinosad Factor D [usan]
10. Unii-78g4631rtt
11. Spinosyn D [mi]
12. Schembl465825
13. Chembl503450
14. Dtxsid3037599
15. Zinc85537011
16. 1h-as-indaceno(3,2-d)oxacyclododecin-7,15-dione, 2-((6-deoxy-2,3,4-tri-o-methyl-alpha-l-mannopyranosyl)oxy)-13-(((2r,5s,6r)-5-(dimethylamino)tetrahydro-6-methyl-2h-pyran-2-yl)oxy)-9-ethyl-2,3,3a,5a,5b,6,9,10,11,12,13,14,16a,16b-tetradecahydro-4,14-dimet
17. Xs175291
18. J-006090
19. Q27108325
20. (2r,3as,5ar,5bs,9s,13s,14r,16as,16br)-2-((6-deoxy-2,3,4-tri-o-methyl-alpha-l-mannopyranosyl)oxy)-13-(((2r,5s,6r)-5-(dimethylamino)tetrahydro-6-methyl-2h-pyran-2-yl)oxy)-9-ethyl-4,14-dimethyl-2,3,3a,5a,5b,6,9,10,11,12,13,14,16a,16b-tetradecahydro-1h-as-indaceno(3,2-d)oxacyclododecin-7,15-dione
21. 1h-as-indaceno(3,2-d)oxacyclododecin-7,15-dione, 2-((6-deoxy-2,3,4-tri-o- Methyl-a-l-mannopyranosyl)oxy)-13-(((2r,5s,6r)-5- (dimethylamino)tetrahydro-6-methyl-2h-pyran-2-yl)oxy)-9-ethyl- 2,3,3a,5a,5b,6,9,10,11,12,13,14,16a,16b-tetradecahydro-4,14-dimethyl-, (2s,3ar,5as,5bs,9s,13s,14r,16as,16bs)-
22. 1h-as-indaceno(3,2-d)oxacyclododecin-7,15-dione, 2-((6-deoxy-2,3,4-tri-o-methyl-alpha-l-mannopyranosyl)oxy)-13-(((2r,5s,6r)-5-(dimethylamino)tetrahydro-6-methyl-2h-pyran-2-yl)oxy)-9-ethyl-2,3,3a,5a,5b,6,9,10,11,12,13,14,16a,16b-tetradecahydro-4,14-dimethyl-, (2s,3ar,5as,5bs,9s,13s,14r,16as,16bs)-
Molecular Weight | 746.0 g/mol |
---|---|
Molecular Formula | C42H67NO10 |
XLogP3 | 4.8 |
Hydrogen Bond Donor Count | 0 |
Hydrogen Bond Acceptor Count | 11 |
Rotatable Bond Count | 9 |
Exact Mass | 745.47649733 g/mol |
Monoisotopic Mass | 745.47649733 g/mol |
Topological Polar Surface Area | 111 Ų |
Heavy Atom Count | 53 |
Formal Charge | 0 |
Complexity | 1330 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 17 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 36707
Submission : 2022-06-01
Status : Active
Type : II
Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.
GDUFA
DMF Review : Reviewed
Rev. Date : 2021-11-15
Pay. Date : 2021-09-16
DMF Number : 36293
Submission : 2021-09-27
Status : Active
Type : II
NDC Package Code : 62227-020
Start Marketing Date : 2021-04-28
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 17795
Submission : 2004-09-29
Status : Active
Type : II
NDC Package Code : 73064-0305
Start Marketing Date : 2007-09-01
End Marketing Date : 2029-05-19
Dosage Form (Strength) : POWDER (50kg/50kg)
Marketing Category : BULK INGREDIENT
VMF Number : 5791
Submission : 2004-01-02
Status : Active
Type : II
GDUFA
DMF Review : Reviewed
Rev. Date : 2024-09-11
Pay. Date : 2024-08-15
DMF Number : 40075
Submission : 2024-07-30
Status : Active
Type : II
NDC Package Code : 53069-1130
Start Marketing Date : 2024-09-16
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 36707
Submission : 2022-06-01
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2021-11-15
Pay. Date : 2021-09-16
DMF Number : 36293
Submission : 2021-09-27
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 17795
Submission : 2004-09-29
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2024-09-11
Pay. Date : 2024-08-15
DMF Number : 40075
Submission : 2024-07-30
Status : Active
Type : II
NDC Package Code : 62227-020
Start Marketing Date : 2021-04-28
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 73064-0305
Start Marketing Date : 2007-09-01
End Marketing Date : 2029-05-19
Dosage Form (Strength) : POWDER (50kg/50kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 62158-0009
Start Marketing Date : 2021-09-23
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 53069-1130
Start Marketing Date : 2024-09-16
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.
About the Company : Established in 1982, ChemWerth is a US-headquartered full-service generic active pharmaceutical ingredient (API) development and supply company. ChemWerth offers cGMP-quality APIs ...
Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.
About the Company : Established in 1994, Rochem is a distributor of pharmaceutical, food, nutritional and animal health ingredients to some of the largest companies in the world. It sources high-quali...
About the Company : Symbiotec, a leading API manufacturing company based in Indore, Central India, specializes in Cortico-Steroids and Steroid-Hormone APIs. Since 1995, their focus on R&D, sustainable...
About the Company : Beijing Mesochem Technology Co. Ltd., which is located in the national economic and technological development area of Yizhuang, China, manufactures pharmaceutical chemicals, fine c...
About the Company : Anhui Sinotech Industrial Co.,Ltd is specially engaged in international marketing of food/feed additive,pesticides and chemicals. We are devoted ourselves to make the life better,a...
About the Company : BrightGene Bio-Medical Technology Co., Ltd. is a research driven biopharmaceutical company that engages in the R&D and manufacturing of innovative medicine as well as special gener...
About the Company : Chongqing Daxin was established in 1941. It is a core member of PKUCare pharmaceutical industry. After nearly 70 year's development, it has become a biotech oriented and comprehens...
About the Company : Hubei Hongzhong Pharmaceutical Co., Ltd. was founded in 2007 and is located in Li Shizhen Pharmaceutical Industrial Park, Qichun County, Hubei Province. The company's products have...
About the Company : Established in 2002, Tecoland represents selected cGMP manufacturers with proven capabilities in organic synthesis, fermentation production as well as process and method developmen...
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Related Excipient Companies
Dosage Form : Tablet
Grade : Oral
Dosage Form : Tablet
Grade : Oral
Application : Fillers, Diluents & Binders
Pharmacopoeia Ref : Conforms to USP-NF, Ph.Eur., J...
Technical Specs : Density- Tapped density- 440 g/l, Bulk density- 280 g/l; Particle size- D10- 25 ?m, D50- 60 ?m, D90-...
Ingredient(s) : Microcrystalline Cellulose
Dosage Form : Tablet
Grade : Oral
Application : Direct Compression
Pharmacopoeia Ref : Conforms to USP-NF, Ph.Eur., J...
Technical Specs : Density- Tapped density- 440 g/l, Bulk density- 310 g/l; Particle size- D10- 40 ?m, D50- 90 ?m, D90...
Ingredient(s) : Microcrystalline Cellulose
Dosage Form : Orodispersible Tablet
Grade : Oral
Application : Disintegrants & Superdisintegrants
Pharmacopoeia Ref : Conforms to USP-NF, Ph.Eur., J...
Technical Specs : Not Available
Ingredient(s) : Croscarmellose Sodium
Dosage Form : Injectable / Parenteral
Grade : Parenteral and Topical
Application : Parenteral
Dosage Form : Cream / Lotion / Ointment
Grade : Topical and Oral
Application : Topical
Dosage Form : Tablet
Grade : Oral
Application : Controlled & Modified Release
Excipient Details : Espheres EM can be used as an inert base for modified release formulations promoting uniformity of release profile.
Pharmacopoeia Ref : Not Available
Technical Specs : Not Available
Ingredient(s) : Microcrystalline Cellulose
Dosage Form : Tablet
Grade : Not Available
Brand Name : Disintequik™ MCC 25
Application : Chewable & Orodispersible Aids
Excipient Details : Direct Tabletting Operations Where Fast Disintegration Is Required
Dosage Form : Tablet
Grade : Oral
Brand Name : Croscarmellose Sodium
Application : Disintegrants & Superdisintegrants
Excipient Details : Cross Carmellose Sodium is fast disintegrating agent or a super-disintegrant used in pharmaceutical tablet formulations.
Pharmacopoeia Ref : Not Available
Technical Specs : Not Available
Ingredient(s) : Croscarmellose Sodium
Dosage Form : Tablet
Grade : Oral
Brand Name : Microcrystalline Cellulos...
Application : Fillers, Diluents & Binders
Excipient Details : Microcrystalline Cellulose is most commonly used filler and binder in drug formulations, together with Lactose.
Pharmacopoeia Ref : Not Available
Technical Specs : Not Available
Ingredient(s) : Microcrystalline Cellulose
Dosage Form : Tablet
Grade : Oral
Brand Name : Microlex® MCC 101
Application : Granulation
Excipient Details : Tablets made from these granules are typically easily disintegrated using conventional super disintegrates even when hard tablets are compressed.
Pharmacopoeia Ref : Monograph- USP/NF, JP/JPE
Technical Specs : Not Available
Ingredient(s) : Microcrystalline Cellulose
Dosage Form : Tablet
Grade : Oral
Brand Name : Microlex® MCC 102
Application : Direct Compression
Pharmacopoeia Ref : Monograph- USP/NF, JP/JPE
Technical Specs : Not Available
Ingredient(s) : Microcrystalline Cellulose
Dosage Form : Tablet
Grade : Oral
Application : Lubricants & Glidants
Excipient Details : Most popular excipient for the production of tablets and capsules. Offering an efficient and low dosage in capsules.
Pharmacopoeia Ref : Monograph- Ph.Eur, USP/NF
Technical Specs : Specific Surface Area-6-10 m2/g; Particle Size-7-11 µm
Ingredient(s) : Magnesium Stearate
Dosage Form : Tablet
Grade : Oral
Application : Lubricants & Glidants
Excipient Details : Higher specific surface area and a smaller median particle size. This product is preferred for more critical and very fine herbal formulations.
Pharmacopoeia Ref : Monograph- Ph.Eur, USP/NF
Technical Specs : Specific Surface Area-8-12 m2/g; Particle Size-5-9 µm
Ingredient(s) : Magnesium Stearate
Dosage Form : Tablet
Grade : Oral
Application : Lubricants & Glidants
Pharmacopoeia Ref : Monograph- Ph.Eur, USP/NF
Technical Specs : Specific Surface Area-6-8 m2/g; Particle Size-7-11 µm
Ingredient(s) : Magnesium Stearate
Dosage Form : Tablet
Grade : Oral
Application : Lubricants & Glidants
Pharmacopoeia Ref : Monograph- Ph.Eur, USP/NF
Technical Specs : Not Available
Ingredient(s) : Magnesium Stearate
Dosage Form : Tablet
Grade : Oral
Application : Lubricants & Glidants
Excipient Details : Meets Kosher and Halal preparations in Jewish and Arab cultures. Qualified in high specification standards requested by European formulators.
Pharmacopoeia Ref : Monograph- Ph.Eur, USP/NF
Technical Specs : Not Available
Ingredient(s) : Magnesium Stearate
Dosage Form : Tablet
Grade : Oral
Dosage Form : Tablet
Grade : Oral
Dosage Form : Capsule
Grade : Oral
Application : Fillers, Diluents & Binders
Dosage Form : Tablet
Grade : Oral
Dosage Form : Tablet
Grade : Oral
Application : Lubricants & Glidants
Dosage Form : Tablet
Grade : Not Available
Application : Fillers, Diluents & Binders
Excipient Details : Helps to manufacture Oral Dosage and Nutraceutical forms by acting as a filler-binder while serving as a fibre source for your customers.
Pharmacopoeia Ref : EP/USP/JP
Technical Specs : Not Available
Ingredient(s) : Microcrystalline Cellulose
Dosage Form : Tablet
Grade : Not Available
Application : Disintegrants & Superdisintegrants
Excipient Details : It is a superdisintegrant that provides an efficient disintegration at low level of use
Dosage Form : Cream / Lotion / Ointment
Grade : Not Available
Application : Thickeners and Stabilizers
Excipient Details : A co-processed product used as a secondary stabilizer and suspension agent in semi-solides formulas.
Pharmacopoeia Ref : EP/USP/JP
Technical Specs : Not Available
Ingredient(s) : Colloidal Microcrystalline Cellulose
Dosage Form : Cream / Lotion / Ointment
Grade : Not Available
Application : Thickeners and Stabilizers
Excipient Details : A co-processed product used as a secondary stabilizer and suspension agent in semi-solides formulas.
Pharmacopoeia Ref : EP/USP/JP
Technical Specs : Not Available
Ingredient(s) : Colloidal Microcrystalline Cellulose
Dosage Form : Cream / Lotion / Ointment
Grade : Not Available
Application : Thickeners and Stabilizers
Excipient Details : A co-processed product used as a secondary stabilizer and suspension agent in semi-solides formulas.
Pharmacopoeia Ref : EP/USP/JP
Technical Specs : Not Available
Ingredient(s) : Colloidal Microcrystalline Cellulose
Dosage Form : Cream / Lotion / Ointment
Grade : Not Available
Brand Name : TABULOSE® SC 591F
Application : Thickeners and Stabilizers
Excipient Details : A co-processed product used as a secondary stabilizer and suspension agent in semi-solides formulas.
Pharmacopoeia Ref : EP/USP/JP
Technical Specs : Not Available
Ingredient(s) : Colloidal Microcrystalline Cellulose
Dosage Form : Cream / Lotion / Ointment
Grade : Not Available
Application : Thickeners and Stabilizers
Excipient Details : A co-processed product used as a secondary stabilizer and suspension agent in semi-solides formulas.
Pharmacopoeia Ref : EP/USP/JP
Technical Specs : Not Available
Ingredient(s) : Colloidal Microcrystalline Cellulose
Dosage Form : Cream / Lotion / Ointment
Grade : Not Available
Application : Thickeners and Stabilizers
Excipient Details : A co-processed product used as a secondary stabilizer and suspension agent in semi-solides formulas.
Pharmacopoeia Ref : EP/USP/JP
Technical Specs : Not Available
Ingredient(s) : Colloidal Microcrystalline Cellulose
Dosage Form : Tablet
Grade : Oral
Application : Fillers, Diluents & Binders
Excipient Details : It is used as a filler in formulation.
Pharmacopoeia Ref : Not Available
Technical Specs : Also Available as Comprecel M102, M102CG, M103, M105, M124, M113, M200, M224, M301, M302
Ingredient(s) : Microcrystalline Cellulose
Dosage Form : Capsule
Grade : Not Available
Application : Disintegrants & Superdisintegrants
Excipient Details : It is used as a disintegrating agent.
Pharmacopoeia Ref : Not Available
Technical Specs : Also Available as Disolcel® GF
Ingredient(s) : Croscarmellose Sodium
Dosage Form : Tablet
Grade : Oral
Application : Lubricants & Glidants
Excipient Details : It is used as a lubricant.
Pharmacopoeia Ref : Not Available
Technical Specs : Not Available
Ingredient(s) : Magnesium Stearate
Dosage Form : Solution
Grade : Oral, Topical
Application : Solubilizers
Excipient Details : Hydrosol 50 is used as a solubilizer and emulsifying agent in oral and topical liquid and semi-solid dosage forms.
Pharmacopoeia Ref : USP/NF
Technical Specs : N/A
Ingredient(s) : Polyoxyl 40 Hydrogenated Castor Oil
Excipients by Applications
19 Sep 2016
// EDQM
https://www.pharmacompass.com/pdf/news/zhejiang-hisun-pharmaceutical-co-ltd-yantou-campus-fails-edqm-inspection-1483966941.pdf
Global Sales Information
Dosage Form : SUSPENSION;TOPICAL
Dosage Strength : 0.9%
Price Per Pack :
Published in :
Country : USA
RX/OTC/DISCN : RX
Market Place
Reply
13 Dec 2021
Reply
25 Sep 2021
Reply
24 Feb 2021
Reply
20 Jan 2021
Reply
16 Dec 2019
Reply
08 Oct 2019
Reply
04 Oct 2019
Reply
10 Jul 2018
Patents & EXCLUSIVITIES
ABOUT THIS PAGE
80
PharmaCompass offers a list of Spinosyn D API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Spinosyn D manufacturer or Spinosyn D supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Spinosyn D manufacturer or Spinosyn D supplier.
PharmaCompass also assists you with knowing the Spinosyn D API Price utilized in the formulation of products. Spinosyn D API Price is not always fixed or binding as the Spinosyn D Price is obtained through a variety of data sources. The Spinosyn D Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Spinosad manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Spinosad, including repackagers and relabelers. The FDA regulates Spinosad manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Spinosad API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Spinosad manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Spinosad supplier is an individual or a company that provides Spinosad active pharmaceutical ingredient (API) or Spinosad finished formulations upon request. The Spinosad suppliers may include Spinosad API manufacturers, exporters, distributors and traders.
click here to find a list of Spinosad suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Spinosad DMF (Drug Master File) is a document detailing the whole manufacturing process of Spinosad active pharmaceutical ingredient (API) in detail. Different forms of Spinosad DMFs exist exist since differing nations have different regulations, such as Spinosad USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Spinosad DMF submitted to regulatory agencies in the US is known as a USDMF. Spinosad USDMF includes data on Spinosad's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Spinosad USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Spinosad suppliers with USDMF on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Spinosad as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Spinosad API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Spinosad as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Spinosad and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Spinosad NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Spinosad suppliers with NDC on PharmaCompass.
Spinosad Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Spinosad GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Spinosad GMP manufacturer or Spinosad GMP API supplier for your needs.
A Spinosad CoA (Certificate of Analysis) is a formal document that attests to Spinosad's compliance with Spinosad specifications and serves as a tool for batch-level quality control.
Spinosad CoA mostly includes findings from lab analyses of a specific batch. For each Spinosad CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Spinosad may be tested according to a variety of international standards, such as European Pharmacopoeia (Spinosad EP), Spinosad JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Spinosad USP).